Hayes M M, Wear D J, Lo S C
Department of Infectious and Parasitic Disease Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000.
Arch Pathol Lab Med. 1991 May;115(5):464-6.
Mycoplasma fermentans (incognitus strain) has recently been recognized as a possible infectious pathogen in humans. This mycoplasma is associated with an acute fatal disease in previously healthy patients who do not have the acquired immunodeficiency syndrome. Many patients with the acquired immunodeficiency syndrome suffer a systemic infection with this microbe. Quantitative assay of antimicrobial susceptibility for M fermentans (incognitus strain) in cultures to representative antibiotics has revealed that the microbe is not sensitive to erythromycin, the most commonly used antibiotic for human mycoplasma infections. The testing shows that M fermentans (incognitus strain) is sensitive in vitro to the antibiotics tetracycline, doxycycline, chloramphenicol, clindamycin, lincomycin, and ciprofloxacin.
发酵支原体(隐匿株)最近被认为是一种可能感染人类的病原体。这种支原体与先前健康且无获得性免疫缺陷综合征的患者所患的急性致命疾病有关。许多获得性免疫缺陷综合征患者会遭受这种微生物的全身感染。对培养物中发酵支原体(隐匿株)对代表性抗生素的抗菌药敏定量分析表明,该微生物对人类支原体感染最常用的抗生素红霉素不敏感。测试表明,发酵支原体(隐匿株)在体外对四环素、强力霉素、氯霉素、克林霉素、林可霉素和环丙沙星敏感。